Sun, Dec 21, 2014, 6:28 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma, Inc. Message Board

  • naked_finger naked_finger May 8, 2013 12:55 PM Flag

    I like it how ARRY Die

    Very fast. No chance to get out. see you below $5.00 soon.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Good to here from you again! I thought maybe you were hiding for some reason. Let us take a quick review of where all stands here.

      On the negative side, a financing in say 5-12 months is certainly possible if they are not able to garner any partnership bucks in time. That would get you back to about even on the $4.70 short.

      On the positive side:

      . 5 pivital trials (1 launched, 4 soon) ALL paid for with partner cash.
      . 4 mid stage candidates, all suitable for partnering and 2 potentially advanced on their own.
      . Up to $3Billion of potential milestones on partnered drugs (w/o help from those above 4 mentioned compunds).
      . Various scattered programs that we can ignore.

      Given that picture, one would have thought most shorts would have used yesterdays dip to cover wioth a mild loss and be glad to escape with the scalp attached.

      BTW, noticed you changed from "it will be under $3 soon", to $4 soon, now $5. Can't wait for 6,7...

    • I was glad to be stopped out too. This was promoted heavily by a certain group that I follow, when they folded, this went down almost 20% in a day. I got out and not coming back. Thei technology is fine, but doen not guarantee a drug. The problem is that it will take a lot of money to continue and they don't have it. I am sure that the same Company that took ARRY up is the same ones to short it down. That is how they play. This thing will fall for a while. ASCO could not save it.

 
ARRY
4.86+0.06(+1.25%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.